HDAC1 and cancer: In summary, our results demonstrate that transcriptional activation of HDAC1 is the primary mechanism underlying SOX4 supporting cancer stemness and this finding suggests that inhibition of HDAC1 would be an effective therapeutic strategy for human cancer with aberrant SOX4 upregulation.